News Release Investor Contact: Jeffrey Geyer, Jeffrey.Geyer@molinahealthcare.com, 305-317-3012 Media Contact: Caroline Zubieta, Caroline.Zubieta@molinahealthcare.com, 562-951-1588 Molina Healthcare Reports Third Quarter 2025 Financial Results Revises Full Year 2025 Guidance | | Three months ended | | Nine months ended | | | --- | --- | --- | --- | --- | | | September 30, | | September 30, | | | | 2025 | 2024 | 2025 | 2024 | | (In millions, except per-share results) | | | | | | Premium Revenue | $10,841 | $9 ...

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Molina Healthcare, Inc. (NYSE: MOH) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Molina, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/molina-healthcare-inc-class-action. Investors have until December 2, 2025, to ask the Court to be appoin ...

Core Viewpoint - Class action lawsuits have been filed on behalf of shareholders of several publicly-traded companies, with specific deadlines for filing lead plaintiff motions [1] Group 1: Fortinet, Inc. (NASDAQ: FTNT) - Class period is from November 8, 2024, to August 6, 2025, with a lead plaintiff deadline of November 21, 2025 [2] - Allegations include false and misleading statements regarding the refresh cycle's profitability, lack of clarity on upgradeable FortiGate firewalls, and misrepresentation of the refresh momentum [2] Group 2: Molina Healthcare, Inc. (NYSE: MOH) - Class period is from February 5, 2025, to July 23, 2025, with a lead plaintiff deadline of December 2, 2025 [3] - Allegations include failure to disclose adverse facts about medical cost trend assumptions, dependency on low utilization of services for growth, and likely cuts to financial guidance for fiscal year 2025 [3] Group 3: Marex Group plc (NASDAQ: MRX) - Class period is from May 16, 2024, to August 5, 2025, with a lead plaintiff deadline of December 8, 2025 [4] - Allegations include selling over-the-counter financial instruments to itself, inconsistencies in financial statements, and unreliability of Marex's financial disclosures [4]

The upcoming report from Molina (MOH) is expected to reveal quarterly earnings of $3.97 per share, indicating a decline of 33.9% compared to the year-ago period. Analysts forecast revenues of $10.9 billion, representing an increase of 5.4% year over year.The consensus EPS estimate for the quarter has undergone an upward revision of 7.8% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.A ...

Core Viewpoint - The Molina Healthcare class action lawsuit alleges that the company and its executives failed to disclose critical information regarding financial performance and medical cost trends, leading to significant stock price declines during the class period [3][4][5]. Group 1: Class Action Details - The class action lawsuit is titled Hindlemann v. Molina Healthcare, Inc., and covers purchasers of Molina Healthcare securities from February 5, 2025, to July 23, 2025 [1]. - Investors have until December 2, 2025, to seek appointment as lead plaintiff in the lawsuit [1][6]. - The lawsuit claims violations of the Securities Exchange Act of 1934 by Molina Healthcare and its executives [1][3]. Group 2: Allegations Against Molina Healthcare - The lawsuit alleges that Molina Healthcare did not disclose adverse facts about its medical cost trend assumptions and the dislocation between premium rates and medical costs [3]. - It is claimed that Molina's near-term growth relied on reduced utilization of various healthcare services, which was not communicated to investors [3]. - The company’s financial guidance for fiscal year 2025 was likely to be cut due to these undisclosed issues [3]. Group 3: Financial Performance and Stock Impact - On July 7, 2025, Molina Healthcare reported adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures [4]. - The company cut its earnings guidance by 10.2% at the midpoint, indicating ongoing medical cost pressures [4]. - Following the financial disclosures, Molina Healthcare's stock price fell nearly 17% after the second quarter results were announced on July 23, 2025, which included a GAAP net income of $4.75 per diluted share, an 8% decrease year over year [5].

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether Molina and certain of its o ...

Core Viewpoint - A lawsuit has been filed against Molina Healthcare, Inc. and certain senior executives for potential violations of federal securities laws, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1][2]. Group 1: Lawsuit Details - Investors have until December 2, 2025, to request to lead the case, which is pending in the U.S. District Court for the Central District of California [2]. - The lawsuit is titled Hindlemann v. Molina Healthcare, Inc., et al., No. 25-cv-9461 [2]. Group 2: Company Background - Molina Healthcare is a health insurance company providing managed healthcare services to low-income individuals under Medicaid and Medicare programs [3]. - The company previously claimed a "solid" earnings growth profile heading into 2025 and stated it was monitoring utilization patterns to mitigate healthcare cost inflation [3]. Group 3: Financial Performance and Stock Impact - On July 7, 2025, Molina reported Q2 2025 adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [4]. - The company cut its guidance for expected adjusted earnings per share by 10.2% to a range of $21.50 to $22.50 per share [4]. - Following further revelations on July 23, 2025, regarding full-year adjusted earnings expectations of no less than $19.00 per diluted share, Molina's stock price fell by $32.03, or 16.8%, from $190.25 to $158.22 per share [4].

Core Viewpoint - A lawsuit has been filed against Molina Healthcare, Inc. and certain senior executives for potential violations of federal securities laws, with claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1][2]. Group 1: Lawsuit Details - Investors have until December 2, 2025, to request to lead the case, which is pending in the U.S. District Court for the Central District of California [2]. - The lawsuit is titled Hindlemann v. Molina Healthcare, Inc., et al., No. 25-cv-9461 [2]. Group 2: Company Background - Molina Healthcare is a health insurance company that provides managed healthcare services to low-income individuals under Medicaid and Medicare programs [3]. - The company previously claimed a "solid" earnings growth profile heading into 2025 and stated it was able to mitigate negative effects of healthcare cost inflation [3]. Group 3: Financial Performance and Stock Impact - On July 7, 2025, Molina reported Q2 2025 adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines [4]. - The company cut its guidance for expected adjusted earnings per share by 10.2% to a range of $21.50 to $22.50 per share [4]. - Following further revelations on July 23, 2025, Molina expected full-year 2025 adjusted earnings to be no less than $19.00 per diluted share, leading to a stock price drop of $32.03 per share, or 16.8%, from $190.25 to $158.22 [4].

Molina Healthcare (NYSE: MOH ) is currently being heavily penalized by a perceived reduction in profitability due to higher utilization costs in the managed healthcare industry. We believe that new rates for Medicaid andAnalyst’s Disclosure:I/we have a beneficial long position in the shares of MOH either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no busin ...

Core Insights - Molina Healthcare (NYSE: MOH) is facing significant penalties due to a perceived reduction in profitability attributed to increased utilization costs in the managed healthcare industry [1] - The company is expected to be impacted by new rates for Medicaid [1] Company Summary - Molina Healthcare is currently experiencing challenges related to profitability, primarily driven by higher costs associated with healthcare utilization [1] - The market's perception of the company's financial health is negatively influenced by these rising costs [1] Industry Summary - The managed healthcare industry is witnessing increased utilization costs, which is affecting companies like Molina Healthcare [1] - Changes in Medicaid rates are anticipated to further impact the financial performance of companies within this sector [1]